DC federal court declines restraining order sought by Apotex

The District of Columbia federal court has declined to issue a temporary restraining order and preliminary injunction sought by Apotex to stop the FDA from delaying approval of its generic form of AstraZeneca's Prilosec. Apotex had sought to defeat a pediatric exclusivity patent extension on Prilosec.
You must be a registered member of MMM to post a comment.
close

Next Article in Careers


Email Newsletters


Specialty medicines continue to be a hot category, one in which spending has surged behind products that treat medicine's most complex diseases. This eBook lays out the needs and hurdles along the specialty drug pathway, explaining how stakeholders are working to get meds into patients' hands and ease their experience. Click here to download.